Your search returned 4 results.

Results
	1.	A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine. [electronic resource] by Ross, Lisa L Dretler, Robin Gerondelis, Peter Rouse, Elizabeth G Lim, Michael L Lanier, Ernest R Producer: 20060705 In: AIDS (London, England) vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Effect of tenofovir subtraction on HIV plasma viraemia, CD4+ T-cell count and resistance in a patient with baseline K65R and M184V mutations. [electronic resource] by Hsu, Ricky Lanier, Ernest R Rouse, Elizabeth G Oie, Katrina L Pappa, Keith A Ross, Lisa L Producer: 20081015 In: Antiviral therapy vol. 13 Availability: No items available. Save to lists Add to cart (remove)
	3.	Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility. [electronic resource] by Ross, Lisa L Parkin, Neil Gerondelis, Peter Chappey, Colombe Underwood, Mark R St Clair, Marty H Lanier, Ernest R Producer: 20070131 In: Journal of acquired immune deficiency syndromes (1999) vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance. [electronic resource] by Gallant, Joel E Gerondelis, Peter Z Wainberg, Mark A Shulman, Nancy S Haubrich, Richard H St Clair, Marty Lanier, Ernest R Hellmann, Nicholas S Richman, Douglas D Producer: 20040309 In: Antiviral therapy vol. 8 Availability: No items available. Save to lists Add to cart (remove)